| Synthesis and in vitro evaluation of novel 1, 2, 4-triazine derivatives as neuroprotective agents H Irannejad, M Amini, F Khodagholi, N Ansari, SK Tusi, M Sharifzadeh, ... Bioorganic & medicinal chemistry 18 (12), 4224-4230, 2010 | 110 | 2010 |
| Toward the discovery of novel anti‐HIV drugs. Second‐generation inhibitors of the cellular ATPase DDX3 with improved anti‐HIV activity: Synthesis, structure–activity … G Maga, F Falchi, M Radi, L Botta, G Casaluce, M Bernardini, H Irannejad, ... ChemMedChem 6 (8), 1371-1389, 2011 | 106 | 2011 |
| Mannich bases of 7-piperazinylquinolones and kojic acid derivatives: synthesis, in vitro antibacterial activity and in silico study S Emami, E Ghafouri, MA Faramarzi, N Samadi, H Irannejad, ... European journal of medicinal chemistry 68, 185-191, 2013 | 84 | 2013 |
| Design, synthesis, in vivo and in silico evaluation of phenacyl triazole hydrazones as new anticonvulsant agents L Dehestani, N Ahangar, SM Hashemi, H Irannejad, PH Masihi, ... Bioorganic chemistry 78, 119-129, 2018 | 73 | 2018 |
| Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones A Ayati, M Falahati, H Irannejad, S Emami DARU Journal of Pharmaceutical Sciences 20, 1-7, 2012 | 57 | 2012 |
| Synthesis, docking simulation, biological evaluations and 3D-QSAR study of 5-Aryl-6-(4-methylsulfonyl)-3-(metylthio)-1, 2, 4-triazine as selective cyclooxygenase-2 inhibitors H Irannejad, A Kebriaieezadeh, A Zarghi, F Montazer-Sadegh, A Shafiee, ... Bioorganic & Medicinal Chemistry 22 (2), 865-873, 2014 | 56 | 2014 |
| Synthesis and biological evaluation of fluconazole analogs with triazole-modified scaffold as potent antifungal agents SM Hashemi, H Badali, H Irannejad, M Shokrzadeh, S Emami Bioorganic & Medicinal Chemistry 23 (7), 1481-1491, 2015 | 47 | 2015 |
| Anticonvulsant activity of 1, 2, 4-triazine derivatives with pyridyl side chain: synthesis, biological, and computational study H Irannejad, H Nadri, N Naderi, SN Rezaeian, N Zafari, A Foroumadi, ... Medicinal Chemistry Research 24, 2505-2513, 2015 | 40 | 2015 |
| Microwave-assisted synthesis and anticonvulsant activity of 5, 6-bisaryl-1, 2, 4-triazine-3-thiol derivatives H Irannejad, N Naderi, S Emami, RQ Ghadikolaei, A Foroumadi, T Zafari, ... Medicinal Chemistry Research 23, 2503-2514, 2014 | 40 | 2014 |
| Novel triazole alcohol antifungals derived from fluconazole: design, synthesis, and biological activity SM Hashemi, H Badali, MA Faramarzi, N Samadi, MH Afsarian, ... molecular diversity 19 (1), 15-27, 2015 | 39 | 2015 |
| Imidazolylchromanones containing non-benzylic oxime ethers: Synthesis and molecular modeling study of new azole antifungals selective against Cryptococcus gattii M Babazadeh-Qazijahani, H Badali, H Irannejad, MH Afsarian, S Emami European journal of medicinal chemistry 76, 264-273, 2014 | 39 | 2014 |
| Inhibition of LPS-induced apoptosis in differentiated-PC12 cells by new triazine derivatives through NF-κB-mediated suppression of COX-2 N Ansari, F Khodagholi, M Ramin, M Amini, H Irannejad, L Dargahi, ... Neurochemistry international 57 (8), 958-968, 2010 | 38 | 2010 |
| Synthesis, in vitro antifungal activity and in silico study of 3-(1, 2, 4-triazol-1-yl) flavanones S Emami, S Shojapour, MA Faramarzi, N Samadi, H Irannejad European Journal of Medicinal Chemistry 66, 480-488, 2013 | 37 | 2013 |
| Synthesis, in silico, in vitro and in vivo evaluations of isatin aroylhydrazones as highly potent anticonvulsant agents S Emami, M Valipour, FK Komishani, F Sadati-Ashrafi, M Rasoulian, ... Bioorganic Chemistry 112, 104943, 2021 | 35 | 2021 |
| Design, Synthesis and In Vitro Study of 5,6‐Diaryl‐1,2,4‐triazine‐3‐ylthioacetate Derivatives as COX‐2 and β‐Amyloid Aggregation Inhibitors S Dadashpour, T Tuylu Kucukkilinc, O Unsal Tan, K Ozadali, H Irannejad, ... Archiv der Pharmazie 348 (3), 179-187, 2015 | 33 | 2015 |
| Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19 M Valipour, A Zarghi, MA Ebrahimzadeh, H Irannejad Cell Cycle 20 (22), 2321-2336, 2021 | 32 | 2021 |
| Potentiation of low-dose doxorubicin cytotoxicity by affecting p-glycoprotein through caryophyllane sesquiterpenes in hepg2 cells: An in vitro and in silico study A Di Sotto, H Irannejad, M Eufemi, R Mancinelli, L Abete, CL Mammola, ... International journal of molecular sciences 21 (2), 633, 2020 | 26 | 2020 |
| Synthesis and neuroprotective activity of novel 1,2,4-triazine derivatives with ethyl acetate moiety against H 2 O2 and Aβ-induced neurotoxicity T Tuylu Kucukkilinc, K Safari Yanghagh, B Ayazgok, M Ali Roknipour, ... Medicinal Chemistry Research 26, 3057-3071, 2017 | 20 | 2017 |
| Papaverine, a promising therapeutic agent for the treatment of COVID‐19 patients with underlying cardiovascular diseases (CVDs) M Valipour, H Irannejad, S Emami Drug Development Research 83 (6), 1246-1250, 2022 | 19 | 2022 |
| Imidazolylchromanones containing alkyl side chain as lanosterol 14α-demethylase inhibitors: Synthesis, antifungal activity and docking study S Emami, T Banipoulad, H Irannejad, A Foroumadi, M Falahati, ... Journal of Enzyme Inhibition and Medicinal Chemistry 29 (2), 263-271, 2014 | 19 | 2014 |
